MHRA-approved and NICE-recommended options include semaglutide (Wegovy) and tirzepatide (Mounjaro), both available through NHS specialist weight management services or regulated private clinics for eligible patients with obesity and relevant comorbidities
However, other studies have turned up conflicting findings on the effects of supplementation
Given the substantial public attention and the extensive use of these medicationsreported to be used by one in eight U.S
In addition to glucose control, SGLT2 inhibitors have been shown to have beneficial effects on body weight, systolic blood pressure, and on the risks for major cardiovascular and renal events
However, it is important to recognize that weight loss is a multifaceted process that requires a balanced diet, regular exercise, and a healthy lifestyle
Li X, Zhang Q, Zhou X, Guo S, Jiang S, Zhang Y, Zhang R, Dong J, Liao L